Skip to content

Clinical Trial Of Vidang Rajnyadi Kashay In Management Of Diabetes mellitus

Open Randomized Controlled Clinical Trial Of Vidang Rajnyadi Kashay In Management Of Madhumeha (Diabetes Mellitus Type 2) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056360
Enrollment
86
Registered
2023-08-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

DrSiddhi Sujay Yadav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age group between the 20 years to 60 years irrespective to sex religion education socio economical and marital status 2 Newly diagnosed patient of Diabetes MellitusType 2 3 Patient having DM type 2 with Fasting blood sugar level range between 126 200 mg dl Postprandial blood sugar level range between 200 300mg dl

Exclusion criteria

Exclusion criteria: 1 Patient who taking insulin therapy 2 Patient with other systemic diseases 3 Patients with DM type 2 complications 4 Patient who not willing for trial protocol 5 Pregnant woman and lactating mothers

Design outcomes

Primary

MeasureTime frame
Vidang Rajnyadi Kashay Is Effective In Management Of Madhumeha diabetes mellitus type 2Timepoint: 4 weeks

Secondary

MeasureTime frame
1 To study adverse effect of vidang rajnyadi kashay in madhumeha if any 2 To study texual review of madhumeha diabetes mellitus type 2Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Dattatrya Nikam

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta

drdattatryanikam@gmail.com8390616774

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026